Clinical trials: in Monaco
Chronic Pain
The Effectiveness of Continuous Ketamine Infusion (KONTINUE)
There are different treatment for chronic pain. One possible treatment is intravenous infusions of ketamine.
- Trial name
- KONTINUE (NCT06131970)
- Where
- Monaco
- Volunteers
- 80 people
- Sponsor
- Centre Hospitalier Princesse Grace
Traumatic Brain Injury
Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries
The goal of this observational study is to evaluate the performance of UCH-L1 and GFAP combined in patients with a mild traumatic brain injury.
- Trial name
- GUEST (NCT05885529)
- Testing
- UCH-L1 GFAP
- Where
- 15 sites in France, Monaco
- Volunteers
- 1,500 people
- Sponsor
- Centre Hospitalier Princesse Grace
Rectum Cancer
Robotic Low Rectum Anterior Resection
The laparoscopic approach for total mesorectal excision (L-TME) results improved short-term outcomes. However this approach has technical limitations when the pelvis is narrow and deep.
- Trial name
- GROG-R01 (NCT04015804)
- Testing
- Clinical database
- Where
- 19 sites in Belgium, France and 1 more
- Volunteers
- 833 people
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
Paroxysmal Atrial Fibrillation
Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
The NEwTON AF study is a multi-center, global, prospective, single arm study to establish the safety and effectiveness of the IntellaNav StablePoint Catheter and Force-Sensing System in subjects with symptomatic, drug refractory…
- Trial name
- NEwTON AF (NCT04580914)
- Testing
- Treatment with IntellaNav StablePoint Ablation Catheter
- Where
- 47 sites in United States, Austria and 11 more
- Volunteers
- 321 people
- Sponsor
- Boston Scientific Corporation
Ventricular Arrhythmias
Evaluation of Electrocardiographic Measurements by High Density Electrode ECG
Cardiac electrical activity is detected on the body surface with conventional electrocardiography involving 12 leads (ECG 12). A limitation of the current ECG technique is that recordings are obtained from only 6 independent…
- Trial name
- ECG-HD (NCT04921501)
- Testing
- HD ECG, Conventional 12-lead ECG
- Where
- 11 sites in France, Monaco
- Volunteers
- 1,800 people
- Sponsor
- University Hospital, Bordeaux
Axial Spondyloarthritis
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by inflammatory arthritis and enthesitis involving the spine. AxSpA prevalence is around 0.17% of the French population.
- Trial name
- ROC-SPA (NCT03445845)
- Testing
- Secukinumab, TNF blocker, blood specimen
- Where
- 35 sites in France, Monaco
- Volunteers
- 300 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Frail Elderly
Long-term Effects of Interventional Strategies to Prevent Cognitive Decline in Elderly.
The MAPT PLUS study is a two-year extension of follow-up of the patients included in the MAPT preventive study, after completion of the interventions. Subjects in the four groups of the MAPT study will be prospectively followed.
- Trial name
- MAPT-PLUS (NCT01513252)
- Testing
- Gröber and Buschke test
- Where
- 13 sites in France, Monaco
- Volunteers
- 1,028 people, healthy volunteers welcome
- Sponsor
- University Hospital, Toulouse
Smoldering Multiple Myeloma
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.
This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about…
- Trial name
- CARRISMM (NCT04144387)
- Testing
- Myelogram
- Where
- 90 sites in Belgium, France and 1 more
- Volunteers
- 395 people
- Sponsor
- Intergroupe Francophone du Myelome
Alzheimer's Dementia (AD), Family Caregivers
Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study.
EYE-TAR(MA)-Follow-Up is a non-interventionel, long-term follow-up study in subjects who participated to the study referred as EYE-TAR(MA) (NCT04730440) EYE-TAR(MA)-Follow-Up aims to evaluate the long-term impacts of the Training…
- Trial name
- NCT05254873
- Testing
- Long term follow-up
- Where
- Monaco
- Volunteers
- 7 people
- Sponsor
- Association de Recherche Bibliographique pour les Neurosciences
Brain Injuries, Concussion, Brain
The Monaco Initiative for Concussion in Motorsport Pilots
The study aims: to observe a population particularly exposed by the past to brain trauma and concussion: Motorsport Pilots who are retired from a professional practice of motor sport; to report results of their neuro-cognitive…
- Conditions
- Brain Injuries, Concussion, Brain, Sport Injury
- Trial name
- NCT04730167
- Testing
- Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.
- Where
- Monaco
- Volunteers
- 12 people
- Sponsor
- Association de Recherche Bibliographique pour les Neurosciences
End Stage Renal Failure on Dialysis
ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial
This study is designed to etablish the effects of spironolactone in comparison to placebo on the composite endpoint of nonfatal Myocardial Infarction (MI) and acute coronary syndrome, hospitalization for heart failure, nonfatal…
- Trial name
- ALCHEMIST (NCT01848639)
- Testing
- Spironolactone
- Where
- 70 sites in Belgium, France and 1 more
- Volunteers
- 823 people
- Sponsor
- University Hospital, Brest
Lung; Nodule, Liver Metastases
Study of Different Gating Techniques for PET Image of Lung and Liver Lesions
Lesions blurred by respiratory motion are common in fluorine-18 PET/CT studies. To avoid these artefacts, several standard gating correction technics are available.
- Trial name
- PETGATQUANT (NCT05779865)
- Where
- Monaco
- Volunteers
- 29 people
- Sponsor
- Centre Hospitalier Princesse Grace
Head and Neck Squamous Cell Carcinoma
Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
Randomized comparison between standard radiotherapy and hypofractionated split course schedule. Compared to standard radiotherapy, the investigators expect that hypofractionated split course (interruption of 2 weeks) radiotherapy…
- Trial name
- ELAN-RT (NCT01864850)
- Testing
- Standard RT, Hypofractionated RT
- Where
- 2 sites in France, Monaco
- Volunteers
- 202 people
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
Breast Cancer
A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer
-Interventional trials aim at preventing severe RIF occurrence in BC patients selected by individual radiosensitivity: PRAVAPREV-01 will be the first interventional double blind trial that will offer a personalised strategy to…
- Trial name
- PRAVAPREV-01 (NCT04385433)
- Testing
- EXPERIMENTAL ARM, CONTROL GROUP, Standard adjuvant whole breast radiotherapy (50Gy/ 25 fractions to whole breast) followed or not by a boost to tumor bed (16Gy/ 8 fractions)
- Where
- 7 sites in France, Monaco
- Volunteers
- 15 people
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
Infection, Sepsis
Early Identification of SEPsis SIGNs in Emergency Department
Objective of SepSIGN project is to validate biomarkers able to predict the clinical worsening of patients freshly admitted at Emergency Department.
- Trial name
- SepSIGN (NCT04261621)
- Where
- 12 sites in United States, France and 1 more
- Volunteers
- 815 people
- Sponsor
- BioMérieux
Alzheimer's Dementia (AD), Family Caregivers
Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease
EYE-TAR(AD+) is an observational study based on the same design as the princeps EYE-TAR(MA) study, but with a larger number of patients and including an additional evaluation of Facial emotion recognition (based on a more…
- Trial name
- NCT05267028
- Testing
- AD-TAR, AD-Cognitive Stimulation
- Where
- Monaco
- Volunteers
- 16 people
- Sponsor
- Association de Recherche Bibliographique pour les Neurosciences
Recurrent Ovarian Cancer
Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
Bevacizumab has been found to prolong progression free survival in first line, and more recently, in second line treatment for platinum sensitive ovarian cancer patients who had not received prior treatment with bevacizumab.
- Trial name
- MITO16MANGO2b (NCT01802749)
- Testing
- Bevacizumab, Paclitaxel, Carboplatin
- Where
- 82 sites in France, Greece and 3 more
- Volunteers
- 406 people
- Sponsor
- National Cancer Institute, Naples
COVID19, Oxygen Therapy
Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress
The SARS-Cov2 viral pandemic is responsible for a new infectious disease called COVID-19 (CoronaVIrus Disease), is a major health problem.
- Conditions
- COVID19, Oxygen Therapy, Prone Position, Spontaneous Ventilation
- Trial name
- PROVID-19 (NCT04363463)
- Testing
- prone position
- Where
- 19 sites in France, Monaco
- Volunteers
- 268 people
- Sponsor
- Centre Hospitalier Régional d'Orléans
Shoulder Disease, Shoulder Fractures
Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term
This study takes place in the framework of the Post-Market Clinical Follow-up of the FX Solutions Shoulder System. The goal of this PMCF study is to collect clinical data in order to confirm the safety and the performance at a…
- Conditions
- Shoulder Disease, Shoulder Fractures, Shoulder Arthroplasty for Revision of Previous Treatment
- Trial name
- NCT05284357
- Testing
- Shoulder Arthroplasty Surgery with HUMELOCK I & II® Anatomic Shoulder System, Shoulder Arthroplasty Surgery with HUMELOCK II® Reversible System, Shoulder Arthroplasty Surgery with HUMELOCK Reversed® Shoulder System
- Where
- 20 sites in France, Monaco
- Volunteers
- 416 people
- Sponsor
- FX Solutions
Ovarian Cancer
Platine, Avastin and OLAparib in 1st Line
Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line…
- Trial name
- PAOLA-1 (NCT02477644)
- Testing
- Olaparib
- Where
- 163 sites in Austria, Belgium and 9 more
- Volunteers
- 806 people
- Sponsor
- Arcagy Research